Inequities in access to biologic and synthetic DMARDs across 46 European countries

Putrik, Polina; Ramiro, Sofía; K Kvien, Tore; Sokka, Tuulikki; Pavlova, Milena; Uhlig, Till; Boonen, Annelies; Tafaj, Argjent; Harutyunyan, Ruzanna; Radner, Helga; Soroka, Nikolay; Mielants, Herman; Sokolovic, Sekib; Lambova, Sevdalina; Mayer, Miroslav; Charalambous, Paraskevi; Vencovsky, Jiri; Lund Hetland, Merete; Peets, Tõnu; Fautrel, Bruno; Letsveridze, Khatuna; Müller-Ladner, Ulf; Sidiropoulos, Prodromos; Péntek, Márta; Gröndal, Gerdur; FitzGerald, Oliver; Bruno, Seriolo; Togizbayev, Galimzhan; Andersone, Daina; Butrimienė, Irena; Hirsch, Marco; Misevska-Percinkova, Snezana; Cassar, Karen; Deseatnicova, Elena; Mustur, Dusan; Głuszko, Piotr; Tavares, Viviana; Berghea, Florian; Shirinsky, Ivan; Veljkovic, Miodrag; Rovensky, Jozef; Tomsic, Matija; Sivera, Francisca; F. Petersson, Ingemar; Axel, Finckh; Shaydullo, Sharipov; Inanc, Nevsun; Dumenko, Tatyana; Verstappen, Suzanne; Khudoberdiev, Hojimurad

doi:10.1136/annrheumdis-2012-202603

Public

Inequities in access to biologic and synthetic DMARDs across 46 European countries

Published in Annals of the Rheumatic Diseases • Mar 7, 2013

Authors:

Polina Putrik

Sofía Ramiro

Tore K Kvien

Abstract

OBJECTIVES: We investigated access to biologic and synthetic disease modifying drugs (bDMARDs and sDMARDs) in patients with rheumatoid arthritis (RA) across Europe. METHODS: A cross-sectional study at national level was performed in 49 European countries. A questionnaire was sent to one expert, addr...

Subject

Medicine

Per capita

Welfare

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!